These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Modern diagnostics in chronic myeloproliferative diseases (CMPDs). Haferlach T; Kern W; Schnittger S; Schoch C Ann Hematol; 2004; 83 Suppl 1():S59-61. PubMed ID: 15124674 [TBL] [Abstract][Full Text] [Related]
7. Chronic myeloproliferative diseases on a pathologist's desk--a dilemma of distinct entities versus a clinico-pathologic continuum. A descriptive study based on a material from the Polish population. Rudzki Z; Papla B; Stachura J Pol J Pathol; 2004; 55(1):13-23. PubMed ID: 15195702 [TBL] [Abstract][Full Text] [Related]
8. Aberrant expression of transforming growth factor beta-1 (TGF beta-1) per se does not discriminate fibrotic from non-fibrotic chronic myeloproliferative disorders. Bock O; Loch G; Schade U; von Wasielewski R; Schlué J; Kreipe H J Pathol; 2005 Apr; 205(5):548-57. PubMed ID: 15726648 [TBL] [Abstract][Full Text] [Related]
9. Karyotypic patterns in chronic myeloproliferative disorders: report on 74 cases and review of the literature. Mertens F; Johansson B; Heim S; Kristoffersson U; Mitelman F Leukemia; 1991 Mar; 5(3):214-20. PubMed ID: 2013980 [TBL] [Abstract][Full Text] [Related]
10. Karyotype findings and molecular analysis of the bcr gene rearrangement supplementing the histologic classification of chronic myeloproliferative disorders. Werner M; Nolte M; Kaloutsi V; Buhr T; Kausche F; Georgii A Lab Invest; 1995 Apr; 72(4):405-10. PubMed ID: 7723278 [TBL] [Abstract][Full Text] [Related]
11. Gain of 9p due to an unbalanced rearrangement der(9;18): a recurrent clonal abnormality in chronic myeloproliferative disorders. Bacher U; Haferlach T; Schoch C Cancer Genet Cytogenet; 2005 Jul; 160(2):179-83. PubMed ID: 15993276 [TBL] [Abstract][Full Text] [Related]
16. [Molecular diagnosis of chronic myeloproliferative diseases and myelodysplastic syndromes]. Bock O Verh Dtsch Ges Pathol; 2007; 91():140-53. PubMed ID: 18314608 [TBL] [Abstract][Full Text] [Related]
17. Improved detection of chromosomal abnormalities in chronic lymphocytic leukemia by conventional cytogenetics using CpG oligonucleotide and interleukin-2 stimulation: A Belgian multicentric study. Put N; Konings P; Rack K; Jamar M; Van Roy N; Libouton JM; Vannuffel P; Sartenaer D; Ameye G; Speleman F; Herens C; Poirel HA; Moreau Y; Hagemeijer A; Vandenberghe P; Michaux L; Genes Chromosomes Cancer; 2009 Oct; 48(10):843-53. PubMed ID: 19582829 [TBL] [Abstract][Full Text] [Related]
18. The 2008 World Health Organization classification system for myeloproliferative neoplasms: order out of chaos. Tefferi A; Thiele J; Vardiman JW Cancer; 2009 Sep; 115(17):3842-7. PubMed ID: 19472396 [TBL] [Abstract][Full Text] [Related]
19. [ATP and ADP of platelets in chronic myeloproliferative disorders and multiple myeloma]. Terada H; Ohshima M Rinsho Ketsueki; 1989 Jan; 30(1):22-8. PubMed ID: 2716195 [TBL] [Abstract][Full Text] [Related]
20. Distribution of cytogenetic abnormalities in myelodysplastic syndromes, Philadelphia negative myeloproliferative neoplasms, and the overlap MDS/MPN category. Bacher U; Schnittger S; Kern W; Weiss T; Haferlach T; Haferlach C Ann Hematol; 2009 Dec; 88(12):1207-13. PubMed ID: 19415278 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]